These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19317327)

  • 1. Using liver enzymes as screening tests to predict mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2008; 40(3-4):191-203. PubMed ID: 19317327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality associated with bilirubin levels in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2009; 41(1):49-53. PubMed ID: 19518005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(4):251-8. PubMed ID: 18522142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function tests and mortality in a cohort of life insurance applicants.
    Pinkham CA; Krause KJ
    J Insur Med; 2009; 41(3):170-7. PubMed ID: 20377096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Liver Function Tests with Mortality in an Insurance Applicant Population.
    Rigatti SJ; Stout R
    J Insur Med; 2022 Jul; 49(3):172-182. PubMed ID: 36378891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The population distributions, upper normal limits and correlations between liver tests among Australian adolescents.
    George J; Denney-Wilson E; Okely AD; Hardy LL; Aitken R
    J Paediatr Child Health; 2008 Oct; 44(10):579-85. PubMed ID: 19012630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in mortality of insurance applicants with HIV infection.
    Stout RL; Fulks M; Dolan VF
    J Insur Med; 2012; 43(2):67-75. PubMed ID: 22876410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol abuse and liver enzymes (AALE): results of an intercompany study of mortality.
    Titcomb C; Braun R; Roudebush B; Mast J; Woodman H;
    J Insur Med; 2001; 33(3):277-89. PubMed ID: 11558411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum globulin predicts all-cause mortality for life insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dependency on age of laboratory values in dogs and cats. 1. Enzyme activities in blood serum].
    Kraft W; Hartmann K; Dereser R
    Tierarztl Prax; 1995 Oct; 23(5):502-8. PubMed ID: 8585065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin and all-cause mortality risk in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2010; 42(1):11-7. PubMed ID: 21290995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolically healthy but obese individuals: relationship with hepatic enzymes.
    Messier V; Karelis AD; Robillard ME; Bellefeuille P; Brochu M; Lavoie JM; Rabasa-Lhoret R
    Metabolism; 2010 Jan; 59(1):20-4. PubMed ID: 19709695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trials.
    Cantilena LR; Cherstniakova SA; Saviolakis G; Kahn R; Elkashef A; Rose L; Vocci F
    Contemp Clin Trials; 2007 Nov; 28(6):695-704. PubMed ID: 17544338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative mortality in asymptomatic men issued standard insurance with routine ECG classified as normal or with minor T wave changes.
    Singer RB
    J Insur Med; 2008; 40(3-4):186-90. PubMed ID: 19317326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory and biometric predictors of cancer-related mortality in an insured population.
    Palmier J; Lanzrath BJ
    J Insur Med; 2012; 43(3):162-8. PubMed ID: 23451617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treadmill value in apparently healthy life insurance applicants.
    Mihelic AH; Tak JA; Rullestad C
    J Insur Med; 2002; 34(1):12-25. PubMed ID: 15303590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of hemoglobin A1c to mortality in nonsmoking insurance applicants.
    Stout RL; Fulks M; Dolan VF; Magee ME; Suarez L
    J Insur Med; 2007; 39(3):174-81. PubMed ID: 18251376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.